Cargando…
Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study
SIMPLE SUMMARY: Judging the chance (risk) of cancer spread and bad outcome in endometrial cancer continues to be a challenge. Molecular and clinical factors offer the hope of improving the accuracy of judging the danger of cancer spread (metastasis) and a bad outcome (prognosis) to help guide patien...
Autores principales: | Casablanca, Yovanni, Wang, Guisong, Lankes, Heather A., Tian, Chunqiao, Bateman, Nicholas W., Miller, Caela R., Chappell, Nicole P., Havrilesky, Laura J., Wallace, Amy Hooks, Ramirez, Nilsa C., Miller, David S., Oliver, Julie, Mitchell, Dave, Litzi, Tracy, Blanton, Brian E., Lowery, William J., Risinger, John I., Hamilton, Chad A., Phippen, Neil T., Conrads, Thomas P., Mutch, David, Moxley, Katherine, Lee, Roger B., Backes, Floor, Birrer, Michael J., Darcy, Kathleen M., Maxwell, George Larry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454742/ https://www.ncbi.nlm.nih.gov/pubmed/36077609 http://dx.doi.org/10.3390/cancers14174070 |
Ejemplares similares
-
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study
por: Goodfellow, Paul J., et al.
Publicado: (2015) -
Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)
por: Santin, Alessandro D., et al.
Publicado: (2020) -
Corrigendum to “Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)” [Gynecol. Oncol. Rep. 31 (2020) 100532]
por: Santin, Alessandro D., et al.
Publicado: (2020) -
Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis
por: Davidson, Brittany A., et al.
Publicado: (2016) -
Gene Expression Analysis of Early Stage Endometrial Cancers Reveals Unique Transcripts Associated with Grade and Histology but Not Depth of Invasion
por: Risinger, John I., et al.
Publicado: (2013)